RGEN - REPLIGEN CORP
125.03
-0.810 -0.648%
Share volume: 686,547
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$125.84
-0.81
-0.01%
Summary score
41%
Profitability
28%
Dept financing
39%
Liquidity
75%
Performance
45%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
2.13%
Return on assets
1.76%
Return on sales
18.64%
Return on invested capital
4.38%
Total debt ratio
36.39%
Debt ratio change over timeo
0%
Current Ratio
9.39%
Quick Ratio
8.18%
Cash Position Ratio
6.6%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
2.49%
Return on assets
1.81%
Return on sales
18.82%
Return on invested capital
4.84%
Total debt ratio
35.09%
Debt ratio change over timeo
0%
Current Ratio
9.02%
Quick Ratio
7.81%
Cash Position Ratio
6.3%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
0.81%
Return on assets
0.4%
Return on sales
8.12%
Return on invested capital
1.21%
Total debt ratio
21.43%
Debt ratio change over time
0%
Current Ratio
1.95%
Quick Ratio
1.63%
Cash Position Ratio
1.35%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RGEN | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 2.13% | 6.52% | 16.07% | 8% |
| Return on assets | 1.76% | 3.2% | 7.46% | 5.12% |
| Return on sales | 18.64% | 44.03% | 59.59% | 42.46% |
| Return on invested capital | 4.38% | 9.05% | 13.06% | 8.23% |
| Profitability | 25% | 57% | 100% | 63% |
| Total debt ratio | 36.39% | 60.67% | 65.75% | 46.57% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 39% | 23% | 25% | 18% |
| Current Ratio | 9.02% | 5.2% | 2.96% | 2.29% |
| Quick Ratio | 7.81% | 4.88% | 2.8% | 1.99% |
| Cash Position Ratio | 6.3% | 0.33% | 1.09% | 0.45% |
| Liquididy | 75% | 28% | 18% | 16% |
| Short-term ratios | RGEN | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 2.49% | 6.57% | 13.54% | 7.21% |
| Return on assets | 1.81% | 3.23% | 6.63% | 5.05% |
| Return on sales | 18.82% | 44.59% | 57.77% | 41.29% |
| Return on invested capital | 4.84% | 9.41% | 12.01% | 7.62% |
| Profitability | 30% | 63% | 100% | 66% |
| Total debt ratio | 35.09% | 60.55% | 63.84% | 45.95% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 39% | 24% | 25% | 18% |
| Current Ratio | 9.02% | 5.2% | 2.96% | 2.29% |
| Quick Ratio | 7.81% | 4.88% | 2.8% | 1.99% |
| Cash Position Ratio | 6.3% | 0.33% | 1.09% | 0.45% |
| Liquididy | 75% | 31% | 21% | 15% |